Close Menu

NEW YORK – OraSure Technologies said Monday it has been awarded a $710,310 contract from Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) to develop a pan-SARS-coronavirus antigen test that uses oral fluid samples. 

The firm said that the contract will support OraSure's filing for Emergency Use Authorization from the US Food and Drug Administration that would enable use of a coronavirus self-test in US homes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.